Serplulimab

Item number	Size	Delivery time	Price
TGM-T76717-1mg	1 mg	7 - 10 business days*	120.00€
TGM-T76717-5mg	5 mg	7 - 10 business days*	371.00€
TGM-T76717-10mg	10 mg	7 - 10 business days*	596.00€
TGM-T76717-25mg	25 mg	7 - 10 business days*	935.00€
TGM-T76717-50mg	50 mg	7 - 10 business days*	1,259.00€
TGM-T76717-100mg	100 mg	7 - 10 business days*	1,690.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab... more

Close menu

Product information "Serplulimab"

Description: Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma. Target: COX. References: Lee A. Serplulimab: First Approval. Drugs. 2022 Jul,82(10):1137-1141.

Keywords:	HLX 10
Supplier:	TargetMol
Supplier-Nr:	T76717

Properties

Application:	Targets programmed cell death protein 1 (PDCD1, PD1, CD279)
Conjugate:	No

Database Information

CAS :	2231029-82-4\| Matching products
KEGG ID :	K06744 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Serplulimab"

Write a review